Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications
Source abstract
Abstract
Originally discovered almost a century ago, cocrystals continue to gain interest in the modern day due to their\nability to modify the physical properties of solid-state materials, particularly pharmaceuticals. Intensification of cocrystal\nresearch efforts has been accompanied by an expansion of the potential applications where cocrystals can offer a benefit. Where\nonce solubility manipulation was seen as the primary driver for cocrystal formation, cocrystals have recently been shown to\nprovide attractive options for taste masking, mechanical property improvement, and intellectual property generation and\nextension. Cocrystals are becoming a commercial reality with a number of cocrystal products currently on the market and more\nfollowing in registration and clinical trial phases. Increased commercialization of cocrystals has in turn necessitated additional\nresearch on methods to make cocrystals, with particular emphasis placed on emerging technologies that can offer\nenvironmentally attractive and efficient options. Methods of producing cocrystals and of harnessing the bespoke physical\nproperty adjustment provided by cocrystals are reviewed in this article, with a particular focus on emerging trends in these areas.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Energetic Materials and Combustion
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Synthesis & Solid State Pharmaceutical Centre (SSPC), Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland
Funding
Science Foundation Ireland
References (100+)
Show source-provided references
1. 10.1021/cg300294810.1021/cg3002948 ↗
2. 10.1039/C5CC08216A10.1039/C5CC08216A ↗
3. 10.1021/acs.molpharmaceut.5b0084310.1021/acs.molpharmaceut.5b00843 ↗
4. 10.1021/cg301088210.1021/cg3010882 ↗
5. Sekhon B. S. · International Journal of Agrochemicals and Plant Protection · 2014 · 2 · 44
6. 10.1039/c3ce41013g10.1039/c3ce41013g ↗
7. 10.1039/B904616J10.1039/B904616J ↗
8. 10.1021/cg500245e10.1021/cg500245e ↗
9. 10.1021/cg050125l10.1021/cg050125l ↗
10. 10.1021/cg060327x10.1021/cg060327x ↗
11. 10.1021/op300214p10.1021/op300214p ↗
12. 10.1517/17425247.2013.74750810.1517/17425247.2013.747508 ↗
13. 10.1016/j.apsb.2015.07.00310.1016/j.apsb.2015.07.003 ↗
14. 10.1016/j.addr.2016.04.02210.1016/j.addr.2016.04.022 ↗
15. 10.1016/j.addr.2017.03.00310.1016/j.addr.2017.03.003 ↗
16. 10.1021/cg901002y10.1021/cg901002y ↗
17. 10.3797/scipharm.cespt.8.PDD3310.3797/scipharm.cespt.8.PDD33 ↗
18. 10.1039/C6CE00353B10.1039/C6CE00353B ↗
19. 10.1021/mp200043u10.1021/mp200043u ↗
20. 10.1039/B812264D10.1039/B812264D ↗
21. 10.1039/C004371K10.1039/C004371K ↗
22. 10.1021/acs.molpharmaceut.5b0025010.1021/acs.molpharmaceut.5b00250 ↗
23. 10.1021/mp070009910.1021/mp0700099 ↗
24. 10.1021/cg401673z10.1021/cg401673z ↗
25. 10.1021/cg800764n10.1021/cg800764n ↗
26. 10.3109/03639045.2011.63326310.3109/03639045.2011.633263 ↗
27. 10.1021/cg049654010.1021/cg0496540 ↗
28. 10.1016/j.ejps.2010.08.01210.1016/j.ejps.2010.08.012 ↗
29. 10.1021/cg100099w10.1021/cg100099w ↗
30. 10.1021/cg101638810.1021/cg1016388 ↗
31. 10.1021/cg101609210.1021/cg1016092 ↗
32. 10.1021/acs.cgd.6b0176910.1021/acs.cgd.6b01769 ↗
33. 10.1021/cg800936d10.1021/cg800936d ↗
34. 10.1016/j.addr.2017.07.00110.1016/j.addr.2017.07.001 ↗
35. 10.1016/j.ejps.2016.02.01710.1016/j.ejps.2016.02.017 ↗
36. 10.1039/c0cc01195a10.1039/c0cc01195a ↗
37. 10.1039/C1CS15171A10.1039/C1CS15171A ↗
38. 10.1039/CT893630131410.1039/CT8936301314 ↗
39. 10.1007/BF0054035810.1007/BF00540358 ↗
40. Baláž P. · 2008 · 1
41. 10.1021/cg800764n10.1021/cg800764n ↗
42. 10.1039/b709411f10.1039/b709411f ↗
43. 10.1038/nmat184810.1038/nmat1848 ↗
44. 10.1039/b408971e10.1039/b408971e ↗
45. 10.1021/cg050168210.1021/cg0501682 ↗
46. 10.1002/chem.20070118410.1002/chem.200701184 ↗
47. 10.1021/cg800889310.1021/cg8008893 ↗
48. 10.1039/b801713c10.1039/b801713c ↗
49. 10.1021/mp800092t10.1021/mp800092t ↗
50. 10.1039/b400978a10.1039/b400978a ↗
51. 10.3390/pharmaceutics303058210.3390/pharmaceutics3030582 ↗
52. 10.1039/C3FD00153A10.1039/C3FD00153A ↗
53. 10.1080/0363904070152562710.1080/03639040701525627 ↗
54. 10.1002/jps.2194210.1002/jps.21942 ↗
55. 10.1016/j.ijpharm.2011.12.03310.1016/j.ijpharm.2011.12.033 ↗
56. 10.1039/C3CE42457J10.1039/C3CE42457J ↗
57. 10.1021/acs.cgd.6b0040210.1021/acs.cgd.6b00402 ↗
58. 10.1016/j.ijpharm.2015.07.02510.1016/j.ijpharm.2015.07.025 ↗
59. 10.1021/cg401375a10.1021/cg401375a ↗
60. 10.1007/s11095-010-0273-910.1007/s11095-010-0273-9 ↗
61. 10.1021/acs.molpharmaceut.6b0013410.1021/acs.molpharmaceut.6b00134 ↗
62. 10.1007/s11095-011-0605-410.1007/s11095-011-0605-4 ↗
63. 10.1016/j.ejpb.2013.04.02210.1016/j.ejpb.2013.04.022 ↗
64. 10.3390/cryst701001310.3390/cryst7010013 ↗
65. 10.1016/j.ejps.2014.06.01710.1016/j.ejps.2014.06.017 ↗
66. 10.1039/b818268j10.1039/b818268j ↗
67. 10.1016/j.tips.2012.12.00310.1016/j.tips.2012.12.003 ↗
68. 10.1039/C4CE01495B10.1039/C4CE01495B ↗
69. 10.1007/s11095-012-0709-510.1007/s11095-012-0709-5 ↗
70. 10.3390/cryst402012310.3390/cryst4020123 ↗
71. 10.1021/cg501310d10.1021/cg501310d ↗
72. 10.1021/cg500560w10.1021/cg500560w ↗
73. 10.1039/B813058B10.1039/B813058B ↗
74. 10.1016/j.ces.2015.01.04510.1016/j.ces.2015.01.045 ↗
75. 10.1016/j.jcrysgro.2014.02.00310.1016/j.jcrysgro.2014.02.003 ↗
76. 10.1021/mp050099m10.1021/mp050099m ↗
77. 10.1021/cg800632r10.1021/cg800632r ↗
78. 10.1002/jps.2243410.1002/jps.22434 ↗
79. 10.1021/op500145a10.1021/op500145a ↗
80. 10.1016/j.ejps.2009.05.01010.1016/j.ejps.2009.05.010 ↗
81. 10.1021/acs.cgd.5b0020010.1021/acs.cgd.5b00200 ↗
82. 10.1021/acs.cgd.5b0087610.1021/acs.cgd.5b00876 ↗
83. 10.1007/s11095-014-1498-910.1007/s11095-014-1498-9 ↗
84. 10.1208/s12249-012-9866-410.1208/s12249-012-9866-4 ↗
85. 10.1021/acs.oprd.5b0027910.1021/acs.oprd.5b00279 ↗
86. 10.1016/j.cej.2016.05.12910.1016/j.cej.2016.05.129 ↗
87. 10.1016/j.jcou.2015.11.00610.1016/j.jcou.2015.11.006 ↗
88. 10.1016/j.supflu.2010.01.01010.1016/j.supflu.2010.01.010 ↗
89. 10.1016/j.supflu.2013.12.01110.1016/j.supflu.2013.12.011 ↗
90. 10.1021/cg401131x10.1021/cg401131x ↗
91. 10.1021/acs.cgd.6b0028910.1021/acs.cgd.6b00289 ↗
92. 10.1039/C0CE00284D10.1039/C0CE00284D ↗
93. 10.1021/op400339910.1021/op4003399 ↗
94. Masters K. · 1985
95. 10.1007/s11095-007-9475-110.1007/s11095-007-9475-1 ↗
96. 10.1016/j.ejpb.2017.08.00510.1016/j.ejpb.2017.08.005 ↗
97. 10.1002/jps.260073020910.1002/jps.2600730209 ↗
98. 10.1021/cg100451q10.1021/cg100451q ↗
99. 10.1016/j.ejps.2014.06.00110.1016/j.ejps.2014.06.001 ↗
100. 10.1016/j.ijpharm.2017.12.02010.1016/j.ijpharm.2017.12.020 ↗